Training Scientists on QbD Stability Methodologies
Training pharmaceutical scientists in Quality by Design (QbD) stability methodologies is no longer optional—it’s a regulatory and operational necessity. As agencies like the USFDA and EMA increasingly expect QbD principles to underpin stability studies, companies must equip their teams with practical, risk-based skills. This tutorial outlines a structured training approach to build QbD capability across…
Read More “Training Scientists on QbD Stability Methodologies” »